Andrew R. MacRae - Concepedia

Author

Andrew R. MacRae

Also Known As

A R MacRae, A. Macrae, A. R. MacRae, A.R. MacRae, A.R. Macrae, Andrew MacRae, Andrew Macrae, Andrew R MacRae, Andrew R. MacRae, Andrew R. Macrae

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

McMaster University Mayo Clinic in Arizona University of Toronto Women & Infants Hospital of Rhode Island Institute for Clinical Evaluative Sciences

About

Andrew R. MacRae is an author at McMaster University specializing in medicine, cardiovascular disease, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	308
2	Public Health	3	3	166
3	Health Sciences	1	1	26
4	Biochemistry	1	1	26
5	Cellular Physiology	1	1	26

Andrew R. MacRae

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Assessing the Requirement for the 6-Hour Interval between Specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies Andrew R. MacRae, Peter A. Kavsak, Viliam Lustig, Clinical Chemistry	2006	202
Analytic and Clinical Utility of a Next-Generation, Highly Sensitive Cardiac Troponin I Assay for Early Detection of Myocardial Injury Peter A. Kavsak, Andrew R. MacRae, Marie-Jeanne Yerna, Clinical Chemistry	2009	163
Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndrome Wendy Y. Craig, James E. Haddow, Glenn E. Palomaki, Prenatal Diagnosis	2006	112
Short- and Long-Term Risk Stratification Using a Next-Generation, High-Sensitivity Research Cardiac Troponin I (hs-cTnI) Assay in an Emergency Department Chest Pain Population Peter A. Kavsak, Xuesong Wang, Dennis T. Ko, Clinical Chemistry	2009	89
The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction Peter A. Kavsak, Andrew R. MacRae, Viliam Lustig, American Heart Journal Cardiovascular DiseaseEsc/acc RedefinitionMyocardial InfarctionCardiologyAcute Myocardial Infarction	2006	81
Long-Term Health Outcomes Associated with Detectable Troponin I Concentrations Peter A. Kavsak, Alice Newman, Viliam Lustig, Clinical Chemistry	2007	73
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction Peter A. Kavsak, Andrew R. MacRae, Alice Newman, Clinica Chimica Acta ThrombosisContemporary TroponinCardiovascular DiseaseAtherosclerosisMedicine	2007	72
Risk Stratification for Heart Failure and Death in an Acute Coronary Syndrome Population Using Inflammatory Cytokines and N-Terminal Pro-Brain Natriuretic Peptide Peter A. Kavsak, Dennis T. Ko, Alice Newman, Clinical Chemistry	2007	61
Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure Peter A. Kavsak, Andrew R. MacRae, Alice Newman, Clinical Biochemistry InflammationThrombosisC-reactive ProteinHeart FailureCardiovascular Disease	2007	59
Analytical comparison of three different versions of a high-sensitivity cardiac troponin I assay over 10 years Peter A. Kavsak, Andrew Worster, Stephen Hill, Clinica Chimica Acta Cardiac MuscleCardiomyopathyHeart FailureAnalytical ComparisonCardiovascular Disease	2017	30

Page 1